AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$16.32
Tradestie Score
54
Market Cap
$1.50B
P/E Ratio
7.1
Revenue Growth
0.1%
Analyst Upside
+12.0%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.10
|
$2.34B | - | 40 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$83.17
|
$2.33B | - | 46 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$31.94
|
$2.33B | - | 44 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.40
|
$2.23B | - | 57 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.48
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$51.96
|
$2.21B | - | 57 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.24
|
$2.18B | - | 52 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.10
|
$2.08B | - | 43 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.28
|
$2.02B | 821.0 | 36 | Compare |
More AUPH Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry